Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins

  • David R. Meldrum
  • Marcelle I. Cedars
  • Fredesminda Hamilton
  • David Huynh
  • Arthur Wisot
  • Bivian Marr
Reproductive Endocrinology


The purpose of this study was to determine whether gonadotropin-releasing hormone agonist further increases the prolactin rise accompanying ovarian stimulation.


Serum prolactin concentrations were compared between cycles with and cycles without the use of leuprolide acetate (LA) matched for estradiol levels. Relationships of prolactin levels to cycle outcomes were examined.


The study took place at a private fertility center.


Patients were women receiving stimulation for oocyte retrieval using human menopausal gonadotropins.


No interventions were used.

Main Outcome Measures

Serum prolactin level, fertilization rate, embryo quality, and pregnancy were the main outcome measures.


Higher serum prolactin was associated with both higher estradiol levels and use of LA but did not have any effects on fertilization rate, embryo quality, or occurrence of pregnancy.


LA stimulates prolactin release during ovarian stimulation but without apparent consequence.

Key words

leuprolide prolactin fertilization 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hofmann GE, Denis ALC, Scott RJ, Muasher SJ: The incidence of transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on pregnancy outcome. Fertil Steril 1989;52:622–626PubMedGoogle Scholar
  2. 2.
    Reinthaller A, Bieglmayer C, Deutinger J, Csaichick P: Transient hyperprolactinemia during cycle stimulation: Influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment. Fertil Steril 1988;49:432–436PubMedGoogle Scholar
  3. 3.
    Yen SSC, Hoff JD, Lasley BL, Casper RF, Sheehan KL: Induction of prolactin release by LRF and LRF-agonist. Life Sci 1980;26:1963–1967PubMedGoogle Scholar
  4. 4.
    Meldrum DR: GnRH agonists as adjuncts for in vitro fertilization. Obstet Gynecol Serv 1989;44:314–317Google Scholar
  5. 5.
    Blackwell RE, Garrison PN: Inhibition of prolactin secretion by antiserum to the α and β-subunits of gonadotropin. Am J Obstet Gynecol 1987;156:863–867PubMedGoogle Scholar
  6. 6.
    Meldrum DR, Tsao Z, Monro SE, Braunstein GD, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755–757PubMedGoogle Scholar
  7. 7.
    Hummel WP, Clark MR, Talbert LM: Transient hyperprolactinemia during cycle stimulation and its influence on oocyte retrieval and fertilization rates. Fertil Steril 1990;53:677–681PubMedGoogle Scholar
  8. 8.
    Gonen Y, Casper RF: The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilization. J Vitro Fert Embryo Transfer 1989;6:155–159Google Scholar
  9. 9.
    Sopelak VM, Whitworth NS, Norman PF, Cowan BD: Bromocriptine inhibition of anesthesia-induced hyperprolactinemia: Effect on serum and follicular fluid hormones, oocyte fertilization, and embryo cleavage rates during in vitro fertilization. Fertil Steril 1989;52:627–632PubMedGoogle Scholar
  10. 10.
    Smith EM, Anthony FW, Gadd SC, Masson GM: Trial of support treatment with human chorionic gonadotropin in the luteal phase after treatment with buserelin and human menopausal gonadotropin in women taking part in an in vitro fertilization programme. Br Med J 1989;298:1483–1485Google Scholar

Copyright information

© Plenum Publishing Corporation 1992

Authors and Affiliations

  • David R. Meldrum
    • 1
    • 2
  • Marcelle I. Cedars
    • 2
  • Fredesminda Hamilton
    • 1
  • David Huynh
    • 1
  • Arthur Wisot
    • 1
  • Bivian Marr
    • 1
  1. 1.AMI South Bay Hospital IVF Center, Redondo BeachUniversity of California at Los Angeles (UCLA) School of MedicineLos AngelesUSA
  2. 2.Department of Obstetrics and GynecologyUCLALos AngelesUSA

Personalised recommendations